270 related articles for article (PubMed ID: 35874957)
21. SARS-CoV-2 nucleocapsid protein phase separates with G3BPs to disassemble stress granules and facilitate viral production.
Luo L; Li Z; Zhao T; Ju X; Ma P; Jin B; Zhou Y; He S; Huang J; Xu X; Zou Y; Li P; Liang A; Liu J; Chi T; Huang X; Ding Q; Jin Z; Huang C; Zhang Y
Sci Bull (Beijing); 2021 Jun; 66(12):1194-1204. PubMed ID: 33495715
[TBL] [Abstract][Full Text] [Related]
22. Intrinsic factors behind long COVID: IV. Hypothetical roles of the SARS-CoV-2 nucleocapsid protein and its liquid-liquid phase separation.
Eltayeb A; Al-Sarraj F; Alharbi M; Albiheyri R; Mattar EH; Abu Zeid IM; Bouback TA; Bamagoos A; Uversky VN; Rubio-Casillas A; Redwan EM
J Cell Biochem; 2024 Mar; 125(3):e30530. PubMed ID: 38349116
[TBL] [Abstract][Full Text] [Related]
23. Host Cellular RNA Helicases Regulate SARS-CoV-2 Infection.
Ariumi Y
J Virol; 2022 Mar; 96(6):e0000222. PubMed ID: 35107372
[TBL] [Abstract][Full Text] [Related]
24. Liquid-liquid phase separation of nucleocapsid proteins during SARS-CoV-2 and HIV-1 replication.
Chau BA; Chen V; Cochrane AW; Parent LJ; Mouland AJ
Cell Rep; 2023 Jan; 42(1):111968. PubMed ID: 36640305
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
[TBL] [Abstract][Full Text] [Related]
27. The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development.
Yu H; Guan F; Miller H; Lei J; Liu C
Emerg Microbes Infect; 2023 Dec; 12(1):e2164219. PubMed ID: 36583642
[No Abstract] [Full Text] [Related]
28. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
29. Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19.
Loh D; Reiter RJ
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897696
[TBL] [Abstract][Full Text] [Related]
30. Phase separation by the SARS-CoV-2 nucleocapsid protein: Consensus and open questions.
Cascarina SM; Ross ED
J Biol Chem; 2022 Mar; 298(3):101677. PubMed ID: 35131265
[TBL] [Abstract][Full Text] [Related]
31. Insights into how SARS-CoV2 infection induces cytokine storms.
Selva KJ; Chung AW
Trends Immunol; 2022 Jun; 43(6):417-419. PubMed ID: 35537983
[TBL] [Abstract][Full Text] [Related]
32. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
[TBL] [Abstract][Full Text] [Related]
33. CTD of SARS-CoV-2 N protein is a cryptic domain for binding ATP and nucleic acid that interplay in modulating phase separation.
Dang M; Song J
Protein Sci; 2022 Feb; 31(2):345-356. PubMed ID: 34734665
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
[TBL] [Abstract][Full Text] [Related]
35. How does severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) achieve immune evasion?: A narrative review.
Bai Y; Ning K
Medicine (Baltimore); 2024 Apr; 103(16):e37780. PubMed ID: 38640329
[TBL] [Abstract][Full Text] [Related]
36. Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein.
Nakayama EE; Kubota-Koketsu R; Sasaki T; Suzuki K; Uno K; Shimizu J; Okamoto T; Matsumoto H; Matsuura H; Hashimoto S; Tanaka T; Harada H; Tomita M; Kaneko M; Yoshizaki K; Shioda T
Sci Rep; 2022 May; 12(1):8108. PubMed ID: 35577892
[TBL] [Abstract][Full Text] [Related]
37. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
38. Unconventional secretion of unglycosylated ORF8 is critical for the cytokine storm during SARS-CoV-2 infection.
Lin X; Fu B; Xiong Y; Xing N; Xue W; Guo D; Zaky M; Pavani K; Kunec D; Trimpert J; Wu H
PLoS Pathog; 2023 Jan; 19(1):e1011128. PubMed ID: 36689483
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production.
Chen K; Xiao F; Hu D; Ge W; Tian M; Wang W; Pan P; Wu K; Wu J
Viruses; 2020 Dec; 13(1):. PubMed ID: 33396605
[TBL] [Abstract][Full Text] [Related]
40. Overview of SARS-CoV-2 genome-encoded proteins.
Bai C; Zhong Q; Gao GF
Sci China Life Sci; 2022 Feb; 65(2):280-294. PubMed ID: 34387838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
